IHT Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$563K Sell
16,688
-4,064
-20% -$137K 0.02% 659
2025
Q1
$660K Sell
20,752
-1,325
-6% -$42.1K 0.02% 585
2024
Q4
$857K Buy
22,077
+5,769
+35% +$224K 0.03% 505
2024
Q3
$734K Buy
16,308
+5,118
+46% +$230K 0.02% 593
2024
Q2
$467K Sell
11,190
-13,750
-55% -$574K 0.02% 658
2024
Q1
$1.14M Buy
24,940
+2,238
+10% +$102K 0.05% 381
2023
Q4
$1.05M Sell
22,702
-985
-4% -$45.5K 0.05% 374
2023
Q3
$964K Buy
23,687
+610
+3% +$24.8K 0.05% 357
2023
Q2
$1.12M Buy
23,077
+2,685
+13% +$130K 0.06% 314
2023
Q1
$1M Buy
20,392
+5,859
+40% +$289K 0.06% 309
2022
Q4
$735K Buy
14,533
+4,534
+45% +$229K 0.05% 373
2022
Q3
$502K Buy
9,999
+1,030
+11% +$51.7K 0.04% 454
2022
Q2
$438K Buy
8,969
+6,437
+254% +$314K 0.04% 419
2022
Q1
$152K Buy
+2,532
New +$152K 0.01% 729